down arrow

Newland Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000065K2
CNY
8.70
-0.4 (-4.4%)

Jun 26

SHE

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'26
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Net Sales
206.95
670.41
724.14
648.05
624.17
513.84
433.12
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
206.95
670.41
724.14
648.05
624.17
513.84
433.12
Raw Material Cost
141.52
460.22
455.12
405.92
414.03
313.71
241.57
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
71.64
79.36
73.32
61.28
49.07
37.49
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.03
0.24
0.35
0.17
6.96
6.78
3.86
Selling and Distribution Expenses
15.25
40.03
33.76
31.78
33.44
38.92
23.85
Other Expenses
0.68
-3.33
-3.13
-2.63
-4.06
-3.74
-2.23
Total Expenditure (Excl Depreciation)
163.64
538.85
537.24
484.85
475.07
371.10
284.44
Operating Profit (PBDIT) excl Other Income
43.3
131.6
186.9
163.2
149.1
142.7
148.7
Other Income
3.98
15.46
18.52
20.99
3.50
2.32
1.43
Operating Profit (PBDIT)
40.76
192.41
239.49
215.37
173.21
159.53
162.24
Interest
0.03
0.24
0.35
0.17
6.96
6.78
3.86
Exceptional Items
0.99
-0.52
-1.72
-1.42
1.04
0.06
-3.00
Gross Profit (PBDT)
65.42
210.19
269.03
242.14
210.14
200.13
191.55
Depreciation
0.00
57.53
40.07
32.62
24.40
20.86
17.95
Profit Before Tax
41.72
134.12
197.35
181.16
142.88
131.94
137.43
Tax
5.95
14.06
24.34
23.96
11.17
17.11
18.97
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
36.10
121.25
173.63
158.98
132.30
114.98
118.46
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
36.10
121.25
173.63
158.98
132.30
114.98
118.46
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.33
-1.18
-0.62
-1.78
-0.60
-0.15
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
35.77
120.07
173.01
157.20
131.71
114.82
118.46
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,587.13
1,551.34
1,542.19
1,448.02
1,355.94
402.53
313.39
Earnings per share (EPS)
0.09
0.31
0.44
0.41
0.34
0.29
0.3
Diluted Earnings per share
0.09
0.31
0.44
0.41
0.34
0.29
0.3
Operating Profit Margin (Excl OI)
17.77%
17.81%
24.98%
24.96%
23.28%
26.53%
32.98%
Gross Profit Margin
20.16%
28.59%
32.79%
32.99%
26.8%
29.74%
35.87%
PAT Margin
17.44%
18.09%
23.98%
24.53%
21.2%
22.38%
27.35%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Markets Mojo
Analysis not available as Data has been published for only 1 period
Compare Annual Results Of Newland Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
206.95
0
206.95
Other Operating Income
0.00
0.00
0.00
Total Operating income
206.95
0
206.95
Raw Material Cost
141.52
0
141.52
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.03
0
0.03
Selling and Distribution Expenses
15.25
0
15.25
Other Expenses
0.68
0.00
0.68
Total Expenditure (Excl Depreciation)
163.64
0
163.64
Operating Profit (PBDIT) excl Other Income
43.31
0.00
43.31
Other Income
3.98
0
3.98
Operating Profit (PBDIT)
40.76
0
40.76
Interest
0.03
0
0.03
Exceptional Items
0.99
0
0.99
Gross Profit (PBDT)
65.42
0
65.42
Depreciation
0.00
0
0.00
Profit Before Tax
41.72
0
41.72
Tax
5.95
0
5.95
Provisions and contingencies
0
0
0.00
Profit After Tax
36.10
0
36.10
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
36.10
0
36.10
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.33
0
-0.33
Other related items
0.00
0.00
0.00
Consolidated Net Profit
35.77
0
35.77
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,587.13
0
1,587.13
Earnings per share (EPS)
0.09
0
0.09
Diluted Earnings per share
0.09
0
0.09
Operating Profit Margin (Excl OI)
17.77%
0%
0.00
17.77%
Gross Profit Margin
20.16%
0%
0.00
20.16%
PAT Margin
17.44%
0%
0.00
17.44%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 20.69 Million
in Mar 2026

Figures in Million
stock-summary

Annual - Consolidate Net Profit
Consolidate Net Profit 3.58 Million
in Mar 2026

Figures in Million
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.68 Million
in Mar 2026

Figures in Million
Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.77%
in Mar 2026

Figures in %
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."